# Postural test to differentiate primary aldosteronism from low-renin hypertension: a retrospective single-center study

**Authors:** Irene Tizianel, Elena Pagin, Eugenio Ragazzi, Alberto Madinelli, Simona Censi, Chiara Sabbadin, Franco Mantero, Caterina Mian, Mattia Barbot, Giorgia Antonelli, Filippo Ceccato

PMC · DOI: 10.1007/s40618-025-02752-9 · 2025-11-18

## TL;DR

A postural test helps distinguish primary aldosteronism from low-renin hypertension by analyzing renin levels and other factors.

## Contribution

The study introduces the postural stimulation test as a novel method to differentiate primary aldosteronism from low-renin hypertension.

## Key findings

- 96% of primary aldosteronism cases were detected when renin levels remained suppressed during the postural test.
- Renin response during the postural test and hypokalemia are key parameters for distinguishing primary aldosteronism from low-renin hypertension.
- Cluster analysis identified distinct patterns of renin suppression and potassium levels between primary aldosteronism and low-renin hypertension patients.

## Abstract

The diagnostic accuracy of screening and confirmatory tests to differentiate primary aldosteronism (PA) among patients with low-renin hypertension (HTN) is suboptimal. We aimed to assess the role of the postural stimulation test (PST) in differentiating PA from low-renin HTN.

Clinical and endocrine data in clinostatic position (CP) and orthostatic position (OP) during PST were evaluated in 190 hypertensive patients: 80 with PA and 110 with low-renin HTN. Multivariate techniques were computed: Principal Component Analysis (PCA), Partial Least Square-Discriminant Analysis (PLS-DA) and k-means clustering.

PST response differentiated our cohort: 96% of PA were detected in the 56/190 patients with always suppressed renin levels during PST, 80% of patients with low-renin HTN were identified among 56/190 subjects with de-suppression of renin from CP to OP and 78/190 with always measurable renin. Normal potassium and measurable renin in OP were predictors of low-renin HTN. Cluster analysis distinguished PA from low-renin HTN: Cluster 2 included 104/110 low-renin HTN; Cluster 1 PA patients showed a higher frequency of suppressed renin levels at baseline and during PST (100% in CP and 95% in OP, respectively). Cluster 1 low- renin HTN patients had lower potassium and a higher frequency of suppressed renin levels at diagnosis and during PST, compared to Cluster 2. PLS-DA and PCA confirmed that renin in OP, renin response to PST, and hypokalemia were the most relevant parameters for distinguishing PA from low-renin HTN.

Renin response during PST can be used to differentiate PA from low-renin HTN.

The online version contains supplementary material available at 10.1007/s40618-025-02752-9.

## Linked entities

- **Diseases:** primary aldosteronism (MONDO:0001422)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}
- **Diseases:** HTN (MESH:D006973), hypokalemia (MESH:D007008), PA (OMIM:617027)
- **Chemicals:** potassium (MESH:D011188)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13018078/full.md

---
Source: https://tomesphere.com/paper/PMC13018078